<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00742040</url>
  </required_header>
  <id_info>
    <org_study_id>1000012229</org_study_id>
    <nct_id>NCT00742040</nct_id>
  </id_info>
  <brief_title>Rapid Versus Prolonged Inpatient Up-Titration of Captopril</brief_title>
  <official_title>Rapid Versus Prolonged Inpatient Up-Titration of Captopril: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to establish a safe and effective method of
      up-titration of captopril for hospital inpatients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Angiotensin converting enzyme inhibitors (ACEi) are one of the most frequently prescribed
      pediatric cardiac medication and overall their safety in children is widely accepted.
      Pediatric formulary recommendations for ACEi suggest starting with a low initial dose (0.1
      mg/kg), to avoid hypotension, and up-titration for a maintenance dose. However, side ranges
      are quoted for maintenance doses and no guidance is given as to the best method of
      up-titration, The physician is left uncertain of the optimal dose and how best to achieve it.

      The ultimate goal of this study is to be in a position to provide physicians caring for
      children with heart disease information about how to safely up-titrate this widely used
      medication, and by doing so to improve dosing in the wider pediatric population.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">August 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of patients reaching a target dose of 1mg/kg/dose (given three times a day).</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Heart Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Captopril</intervention_name>
    <description>A rapid 3-day up-titration protocol</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Captopril</intervention_name>
    <description>A slower 9-day up-titration protocol</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric cardiology in-patients at The Hospital for Sick Children

          -  Primary physician has decided to commence ACEi (the division has agreed that our
             institutional choice will be to start patients on captopril and up-titrate to optimal
             dose before converting to other ACEi)

          -  Patients who have been initiated on captopril within the prior 24 hours, but have not
             yet started up-titration, will be eligible to be randomized

        Exclusion Criteria:

          -  Known sensitivity to ACEi

          -  Infants on the neonatal intensive care unit

          -  Treatment with any ACEi for more than 24 hours within the preceding 6 months

          -  Age &gt; 18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Kantor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Kantor, MD</last_name>
      <phone>(416)813-7239</phone>
      <email>paul.kantor@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Paul Kantor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucy Roche, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katherine Timberlake, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian McCrindle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mervin Balasingam</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2008</study_first_submitted>
  <study_first_submitted_qc>August 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2008</study_first_posted>
  <last_update_submitted>August 26, 2008</last_update_submitted>
  <last_update_submitted_qc>August 26, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2008</last_update_posted>
  <responsible_party>
    <name_title>Paul Kantor/Principal Investigator</name_title>
    <organization>The Hospital for Sick Children</organization>
  </responsible_party>
  <keyword>up-titration</keyword>
  <keyword>captopril</keyword>
  <keyword>pediatric</keyword>
  <keyword>cardiac patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Captopril</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

